Kristin Yarema

2023

In 2023, Kristin Yarema earned a total compensation of $2.4M as President, Cell Therapy at Poseida Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$171,280
Option Awards$934,210
Salary$380,625
Stock Awards$934,910
Other$13,540
Total$2,434,565

Yarema received $934.9K in stock awards, accounting for 38% of the total pay in 2023.

Yarema also received $171.3K in non-equity incentive plan, $934.2K in option awards, $380.6K in salary and $13.5K in other compensation.

Rankings

In 2023, Kristin Yarema's compensation ranked 400th out of 2,790 executives tracked by ExecPay. In other words, Yarema earned more than 85.7% of executives.

ClassificationRankingPercentile
All
400
out of 2,790
86th
Division
Manufacturing
228
out of 1,530
85th
Major group
Chemicals And Allied Products
161
out of 869
82nd
Industry group
Drugs
158
out of 832
81st
Industry
Biological Products, Except Diagnostic Substances
57
out of 204
72nd
Source: SEC filing on April 25, 2024.

Yarema's colleagues

We found two more compensation records of executives who worked with Kristin Yarema at Poseida Therapeutics in 2023.

2023

Mark Gergen

Poseida Therapeutics

Chief Executive Officer

2023

Brent Warner

Poseida Therapeutics

President, Gene Therapy

News

You may also like